MDXG
MiMedx Group IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$573.47M
P/E Ratio
12.06
EPS
$0.32
Beta
1.65
52W High
$7.99
52W Low
$3.77
50-Day MA
$4.72
200-Day MA
$6.30
Dividend Yield
—
Profit Margin
11.60%
Forward P/E
19.53
PEG Ratio
2.88
About MiMedx Group Inc
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company is headquartered in Marietta, Georgia.
Fundamentals
| Revenue (TTM) | $418.63M |
| Gross Profit (TTM) | $345.62M |
| EBITDA | $78.77M |
| Operating Margin | 17.80% |
| Return on Equity | 21.60% |
| Return on Assets | 13.20% |
| Revenue/Share (TTM) | $2.83 |
| Book Value | $1.73 |
| Price-to-Book | 2.27 |
| Price-to-Sales (TTM) | 1.37 |
| EV/Revenue | 1.037 |
| EV/EBITDA | 5.51 |
| Quarterly Earnings Growth (YoY) | 99.50% |
| Quarterly Revenue Growth (YoY) | 27.10% |
| Shares Outstanding | $148.57M |
| Float | $117.61M |
| % Insiders | 2.34% |
| % Institutions | 73.22% |
Analyst Ratings
Consensus ($9.67 target)
5
BuyData last updated: 4/8/2026